Department of Psychology, University at Buffalo, SUNY, Buffalo, NY 14260, USA.
Exp Physiol. 2010 Jun;95(6):736-45. doi: 10.1113/expphysiol.2010.052191. Epub 2010 Mar 12.
Angiotensin II (Ang II) acts at central type 1 (AT(1)) receptors to increase intake of water and saline. In vitro studies demonstrated rapid desensitization of the AT(1) receptor after Ang II exposure, and behavioural studies in rats suggest that exposure to Ang II decreases the dipsogenic potency of subsequent Ang II. Nevertheless, the effect of repeated Ang II injections on saline intake remains untested, and a reliable protocol for examining this purported behavioural desensitization has not emerged from the literature. To address these issues, we established a reliable approach to study Ang II-induced dipsetic desensitization and used this approach to test the requirement of central AT(1) receptors and the specificity of the effect for water intake. Rats given a treatment regimen of three injections of Ang II (300 ng, intracerebroventricular), each separated by 20 min, drank less water than control rats after a subsequent test injection of Ang II. The effect was relatively short lasting, dependent on the dose and timing of Ang II, and was almost completely blocked by the AT(1) receptor antagonist losartan. In further testing, when rats were given access to both water and 1.5% saline, animals that received an Ang II treatment regimen drank less water than control animals, but saline intake was unaffected. These data support previous suggestions that Ang II-induced water and saline intakes are separable. Given the role of G protein uncoupling in desensitization of the AT(1) receptor, these data are consistent with the emerging hypothesis that AT(1) receptor G protein-dependent intracellular signalling pathways are more relevant for water, but not saline, intake.
血管紧张素 II(Ang II)在中枢型 1 型(AT(1))受体上发挥作用,增加水和盐水的摄入。体外研究表明,Ang II 暴露后 AT(1)受体迅速脱敏,大鼠行为研究表明,暴露于 Ang II 会降低随后 Ang II 的致渴效力。然而,重复 Ang II 注射对盐水摄入的影响尚未得到测试,并且文献中也没有出现一种可靠的方法来检查这种所谓的行为脱敏。为了解决这些问题,我们建立了一种可靠的方法来研究 Ang II 诱导的口渴脱敏,并使用这种方法来测试中枢 AT(1)受体的要求和对水摄入的特异性。给予 Ang II(300 ng,侧脑室)三次注射治疗方案的大鼠,每次间隔 20 分钟,在随后的 Ang II 测试注射后比对照大鼠饮水少。该作用持续时间相对较短,取决于 Ang II 的剂量和时间,并且几乎完全被 AT(1)受体拮抗剂洛沙坦阻断。在进一步的测试中,当大鼠可以接触到水和 1.5%盐水时,接受 Ang II 治疗方案的动物比对照动物饮水少,但盐水摄入不受影响。这些数据支持先前的建议,即 Ang II 诱导的水和盐水摄入是可分离的。鉴于 G 蛋白偶联在 AT(1)受体脱敏中的作用,这些数据与新兴假说一致,即 AT(1)受体 G 蛋白依赖性细胞内信号通路与水摄入更相关,但与盐水摄入无关。